Podcast
Questions and Answers
Which one of the following is true regarding the relationship between lowering HbA1c to 6% or lower and the risk of cardiovascular events in patients with advanced type 2 diabetes at high risk for cardiovascular disease?
Which one of the following is true regarding the relationship between lowering HbA1c to 6% or lower and the risk of cardiovascular events in patients with advanced type 2 diabetes at high risk for cardiovascular disease?
- Lowering HbA1c to 6% or lower decreases the risk of cardiovascular events in these patients.
- The text does not provide information on the relationship between lowering HbA1c to 6% or lower and the risk of cardiovascular events in these patients.
- Lowering HbA1c to 6% or lower has no effect on the risk of cardiovascular events in these patients.
- Lowering HbA1c to 6% or lower increases the risk of cardiovascular events in these patients. (correct)
According to the ACCORD Study Group findings mentioned in the text, what was the effect of setting the treatment target for HbA1c below 6% in high-risk patients?
According to the ACCORD Study Group findings mentioned in the text, what was the effect of setting the treatment target for HbA1c below 6% in high-risk patients?
- It resulted in reduced 5-year nonfatal myocardial infarctions. (correct)
- The text does not provide information on the effect of setting the treatment target for HbA1c below 6% in high-risk patients.
- It resulted in increased 5-year nonfatal myocardial infarctions.
- It had no effect on 5-year nonfatal myocardial infarctions.
What does the text state about the effect of iron and erythropoietin treatments commonly prescribed in patients with chronic kidney disease?
What does the text state about the effect of iron and erythropoietin treatments commonly prescribed in patients with chronic kidney disease?
- The text does not provide information on the effect of these treatments on HbA1c or blood glucose levels.
- These treatments cause a significant increase in HbA1c without affecting blood glucose levels.
- These treatments cause a significant decrease in HbA1c without affecting blood glucose levels. (correct)
- These treatments have no effect on HbA1c or blood glucose levels.
What was a major finding of the United Kingdom Prospective Diabetes Study (UKPDS)?
What was a major finding of the United Kingdom Prospective Diabetes Study (UKPDS)?
According to the 2018 guidance statement by the American College of Physicians (ACP), what HbA1c target should clinicians aim to achieve in most patients with type 2 diabetes?
According to the 2018 guidance statement by the American College of Physicians (ACP), what HbA1c target should clinicians aim to achieve in most patients with type 2 diabetes?
What effect did more frequent visits with a primary care provider have on serum glucose, HbA1c, and LDL cholesterol levels in a study by Morrison et al?
What effect did more frequent visits with a primary care provider have on serum glucose, HbA1c, and LDL cholesterol levels in a study by Morrison et al?
What was a significant implication of the findings from the United Kingdom Prospective Diabetes Study (UKPDS) according to the text?
What was a significant implication of the findings from the United Kingdom Prospective Diabetes Study (UKPDS) according to the text?
What should continue to be stressed throughout treatment for patients with diabetes?
What should continue to be stressed throughout treatment for patients with diabetes?
What does the text suggest is a challenge in implementing a strategy of more frequent visits with a primary care provider globally?
What does the text suggest is a challenge in implementing a strategy of more frequent visits with a primary care provider globally?
Based on the information in the text, what is a potential drawback of aiming for stricter HbA1c targets in patients with type 2 diabetes?
Based on the information in the text, what is a potential drawback of aiming for stricter HbA1c targets in patients with type 2 diabetes?
